[ad_1]
WBA) owns a 26 percent stake in AmerisourceBergen II” data-id=”1172757197″ data-type=”getty-image” width=”6240px” height=”4160px” srcset=”https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1172757197/image_1172757197.jpg?io=getty-c-w1536 1536w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1172757197/image_1172757197.jpg?io=getty-c-w1280 1280w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1172757197/image_1172757197.jpg?io=getty-c-w1080 1080w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1172757197/image_1172757197.jpg?io=getty-c-w750 750w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1172757197/image_1172757197.jpg?io=getty-c-w640 640w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1172757197/image_1172757197.jpg?io=getty-c-w480 480w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1172757197/image_1172757197.jpg?io=getty-c-w320 320w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1172757197/image_1172757197.jpg?io=getty-c-w240 240w” sizes=”(max-width: 768px) calc(100vw – 36px), (max-width: 1024px) calc(100vw – 132px), (max-width: 1200px) calc(66.6vw – 72px), 600px”> jetcityimage/iStock Editorial via Getty Images
- AmerisourceBergen Drug, now known as Cencora (NYSE:COR) awarded an estimated ~$2B modification extending the third two-year six-month option period of a two-year six-month base contract with three two-year six-month option periods for prime vendor pharmaceutical and pharmaceutical-related products and
[ad_2]
Source link
